Ptc Therapeutics PTCT
NASDAQ PTCT
$65.00 -0.95 (-1.44%)
As of: Sep 29, 2026 · 3:59 PM EDT

Ptc Therapeutics (PTCT) Share-based Compensation (2012 - 2026)

Updated

Ptc Therapeutics (PTCT) reported Share-based Compensation of $23.29 million for Q2 2026, up 25.6% from $18.54 million a year earlier but down 0.6% from the prior quarter.

Analysis

Ptc Therapeutics (PTCT) Share-based Compensation (2012 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Ptc Therapeutics' Share-based Compensation came in at $84.66 million, up 15.0% year-over-year; for FY2025, it came in at $74.55 million, down 0.1% from FY2024.

  • Share-based Compensation has declined for three consecutive years, though with a five-year compound annual growth rate of 1.2% (FY2020 to FY2025).
  • By year, Share-based Compensation came in at $74.62 million in FY2024 (-26.6%), $101.64 million in FY2023 (-7.9%), $110.33 million in FY2022 (+6.6%) and $103.51 million in FY2021 (+47.2%).
  • Five-year quarterly Share-based Compensation spans a low of $16.51 million in Q4 2023 and a high of $29.37 million in Q2 2023.
  • Year over year, Share-based Compensation has now increased in each of the last three quarters, with growth averaging 4.2% over the last eight quarters.
  • The high point for year-over-year Share-based Compensation in five years was Q3 2021 (growth of 54.2%); the low point was Q4 2023 (a decline of 39.6%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $23.42 million (Q1 2026), $18.52 million (Q4 2025) and $19.43 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Ptc Therapeutics 5.50 Bn -2.26 Bn 340.60 Mn 23.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.29 Mn
Mar 31, 2026 23.42 Mn
Dec 31, 2025 18.52 Mn
Sep 30, 2025 19.43 Mn
Jun 30, 2025 18.54 Mn
Mar 31, 2025 18.06 Mn
Dec 31, 2024 17.24 Mn
Sep 30, 2024 19.76 Mn
Jun 30, 2024 19.24 Mn
Mar 31, 2024 18.38 Mn
Dec 31, 2023 16.51 Mn
Sep 30, 2023 26.94 Mn
Jun 30, 2023 29.37 Mn
Mar 31, 2023 28.82 Mn
Dec 31, 2022 27.34 Mn
Sep 30, 2022 28.67 Mn
Jun 30, 2022 27.73 Mn
Mar 31, 2022 26.59 Mn
Dec 31, 2021 26.24 Mn
Sep 30, 2021 25.87 Mn
API Access

Ptc Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PTCT&period=max&api_key=YOUR_API_KEY